PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. New research finds a safe way to boost the effects of radiatio...
Continue Reading →
Europe

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company develo...
Continue Reading →
Australasia

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provider of...
Continue Reading →
news

Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compou...
Continue Reading →
Europe

Chronic inflammation linked with increased risk of multiple diseases and shorter lifespan

Researchers have elucidated the disease risk underlying a biomarker predictive of shorter lifespan. Researchers have been able to unravel the disease burden that unde...
Continue Reading →
news

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multic...
Continue Reading →
Europe

Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes

Excellent safety profile reported so far, results expected summer 2019 Liège, Belgium, November 5, 2018 – Imcyse, who develop active specific immunotherapies for the ...
Continue Reading →
Europe

Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases

Candidate molecules have the potential to treat multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and systemic inflammatory disea...
Continue Reading →
Europe

Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma

First dose has been administered in the multiple-center study  BN-Brachyury for the treatment of chordoma received FDA Orphan Drug Designation in May 2018 COPEN...
Continue Reading →
news

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at t...
Continue Reading →
Quotient